Agenda 2026
Coming Soon
We have a full agenda for both days, details of both the morning and afternoon sessions can be found below.
Day 1 - Deep Venous Therapies
- 08:00 - 08:55
Registration
- 08:55 - 09:00
Welcome
Evidence Session
Chair: Dr Marta Ramirez Ortega & Dr Mert Dumantepe
- 09:00 - 09:15
- Key Deep Venous Trials to date - Did they Change Practice? And What’s on the Horizon
- Prof Alun Davies, London
- 09:15 - 09:25
- EVeR Registry Early Results and What we can Learn
- Mr Baris Odezemir, Bristol
- 09:25 - 09:35
- Cost-effectiveness of mechanical thrombectomy versus Anticoagulation for treating iliofemoral DVT
- Miss Anna Pouncey, London
- 09:35 - 09:50
- PANEL DISCUSSION
Hot Topic Debate: IVUS Is Mandatory in Every Venous Intervention
Chairs: Dr Andy Wigham & Miss Hayley Moore
- 09:50 - 10:20
- IVUS Is Mandatory in Every Venous Intervention
- FOR: Dr Narayanan Thulasidasan, London (8+2)
- AGAINST: Prof Olivier Hartung, France (8+2)
- 1020 - 1040
COFFEE BREAK
Acute Ileofemoral DVT
Chairs: Dr Conrad von Stempel & Dr Domenico Baccellieri
- 1040 - 1055
- Picking Winners for thrombus removal in Acute Ileofemoral DVT
- Miss Hayley Moore, Frimley
- 1055 - 1110
- Dedicated Venous Stents: Evolution, Evidence and Future Directions
- Dr Fernando Gallardo, Spain
- 1110 - 1125
- PANEL DISCUSSION
Mechano - thrombectomy Devices in Acute DVT
Chairs: Professor Alun Davies & Prof Olivier Hartung
- 1125 - 1205
- The current evidence and when I use this device?
- Inari ClotTriever
- Miss Emma Wilton, Oxford (10)
- CLEANER Vac
- Dr Narayanan Thulasidasan, London (10)
- Penumbra
- Dr Mohammad Barbati, Germany (10)
- Angiojet (Boston Scientific)
- Dr Mert Dumantepe, Turkey (10)
- 1205 - 1225
- PANEL DISCUSSION
- 1225 - 1310
LUNCH
Management of Non‑Thrombotic Iliac Vein Lesions
Chairs: Mr Baris Odezemir & Miss Emma Wilton
- 1310 - 1325
- Non‑thrombotic iliac vein lesions – are they clinically significant? - when should we treat?
- Mr Andy Wigham, Oxford
- 1325 - 1340
- My approach to Stenting non-thrombotic iliac venous lesion (NIVL) and how it differs to that of thrombotic iliac venous lesions
- Dr Marta Ramirez Ortega, Spain
- 1340 - 1355
- PANEL DISCUSSION
Management of Chronic DVT
Chairs: Dr Fernando Gallardo & Prof Dan Carradice
- 1355 - 1405
- The C-TRACT Trial - does it change practice?
- Miss Emma Wilton, Oxford
- 1405 - 1420
- Chronic venous outflow obstruction - Picking Winners for Intervention and Predicting Failure
- Dr Mohammad Barbati, Germany
- 1420 - 1435
- Complex Iliocaval Reconstruction: Tips, Tricks and Bailouts
- Dr Olivier Hartung, France
- 1435 - 1450
- How should we manage infrainguinal chronic venous obstruction? An Evidence-Based Approach
- Dr Domenico Baccellieri, Italy
- 1450 - 1505
- PANEL DISCUSSION
- 1505 - 1525
COFFEE BREAK
Mixed Cases
Chairs: Dr Mohammad Barbati & Dr Narayanan Thulasidasan
- 1525 - 1535
- Compression After Deep Venous Intervention: Evidence, Practice and Controversies
- Prof Dan Carradice, Hull
- 1535 - 1545
- Non-Radiation Non-Contrast Mechanical Thrombectomy for Pregnancy related Ilio-femoral DVT
- Dr Mert Dumantepe, Turkey
- 1545 - 1555
- Cancer-associated venous thrombosis
- Dr Conrad von Stempel, London
- 1555 - 1605
- Pelvic Vein Incompetence - Who to treat, how to treat - an evidence-based strategy (13+2)
- Dr Lakshmi Ratnam, London
- 1605 - 1620
- PANEL DISCUSSION
Carotid Controversies
Chairs: Dr Tarun Sabharwal & Prof Rob Morgan
- 1620 - 1630
- What should we do about asymptomatic carotid disease considering CREST-2 and ACST-2?
- Prof Alison Halliday, Oxford
- 1630 - 1640
- The Vulnerable Carotid Plaque: How Should Morphology Influence Clinical Decision-Making?
- Dr Nick Evans, Cambridge
- 1640 - 1655
- TCAR: Hype, Hope or Here to Stay?
- Dr Kosmas Paraskevas, Greece
- 1655 - 1710
- Carotid Intravascular Lithotripsy: Innovative Solution or Technology Ahead of the Evidence?
- Dr Piero Montorsi, Italy
- 1710 - 1730
- Panel Discussion & Close of Meeting
- Miss Kaji Sritharan, Meeting Director
- 1730 - 1830
DRINKS RECEPTION
Day 2 - Peripheral Arterial Therapies
- 08:00 - 08:05
Welcome
Breakfast Meeting
Chairs: Prof Clark Zeebregts & Dr Narayanan Thulasidasan
- 08:05 - 08:17
- BASIL-3: Why Didn't Better Devices Produce Better Outcomes?
- Mr Matt Popplewell, Birmingham
- 08:17 - 08:29
- BEST-CLI, BASIL-2 and BASIL-3: Conflicting Results or Different Questions?
- Prof Maarit Venermo, Finland (Remote)
- 08:29 - 08:40
- PANEL DISCUSSION
Aorto - Iliac Disease
Chairs: Dr Andy Wigham & Dr Raj Gali
- 08:40 - 08:50
- Covered or Bare? Choosing the Right Stent for Aorto-Iliac Disease in 2026
- Mr Prakash Saha, London
- 08:50 - 09:00
- Antegrade, Retrograde or Re-entry? Mastering Iliac CTO Intervention
- Dr Colin Primrose, Aberdeen
- 09:00 - 09:10
- The Iliac Case That Changed My Practice
- Dr Narayanan Thulasidasan, London
- 09:10 - 09:25
- PANEL DISCUSSION
Femoro - popliteal Disease (I)
Chairs: Dr Colin Primrose & Dr Rosie Cadwallader
- 09:25 - 09:35
- Atherectomy in the CFA - My Approach and Case Selection
- Mr Craig Nesbitt, Newcastle
- 09:35 - 09:45
- Why Endovascular Interventions Fail: Preventing Restenosis and Improving Long-Term Outcomes
- Dr Konstantinos Stavroulakis, Germany
- 09:45 - 10:00
- Disasters & Bailout - A Tale of 2 SFAs……
- Dr Shemin Mehta, Liverpool
- 1000 - 1015
- PANEL DISCUSSION
- 1015 - 1035
COFFEE BREAK
Femoro - popliteal Disease (II)
Chairs: Prof Martin Andrassy & Prof Alok Tiwari
- 1035 - 1045
- Medtronic Sponsored Talk: The In.Pact Advantage: Evidence, Experience and Economics
- Dr Arun Sebastian, Colchester
- 1045 - 1055
- Cordis Sponsored Talk: Beyond Paclitaxel: Clinical Data and Real-World insights with Selution PTA
- Prof Raghu Lakshminarayan, Hull
- 1055 - 1110
- Is Vessel Preparation Essential Before Drug Delivery? Evidence from the SFA and BTK
- Prof Yann Gouëffic, France
- 1110 - 1125
- PANEL DISCUSSION
Evidence Session (I)
Chair: Prof Jos van den Berg & Prof Yann Gouëffic
- 1125 - 1135
- The Future of PAD Is Not Another Device
- Prof Martin Andrassy, Germany
- 1135 - 1200
- Surveillance post endo intervention is a waste of time and money
-
FOR: Mr Ankur Thapar, Basildon
AGAINST: Dr Ulrich Beschorner, Germany
- 1200 - 1210
- Compression in PAD - are we too cautious - taking a pragmatic approach
- Prof Dan Carradice, Hull
- 1210 - 1225
- PANEL DISCUSSION
- 1225 - 1310
LUNCH
Evidence Session (II)
Chairs: Dr Fabien Lareyre & Prof Athanasios Diamantopoulos
- 1310 - 1320
- Randomised Trials That Have Changed Peripheral Arterial Disease Practice
- Prof Athanasios Saratzis, Leicester
- 1320 - 1330
- When Limb Salvage Is Not Patient Salvage: Recognising Futility in Vascular Care
- Prof Clark Zeebregts, Netherlands
- 1330 - 1340
- How Artificial Intelligence Will Change the Management of Peripheral Arterial Disease
- Dr Fabien Lareyre, France
- 1340 - 1346
- Abstract 1 (4+2) Long-Term Limb Preservation and Low Reintervention Rates in Complex BTK Lesions: Four-Year Outcomes With a Retrievable Scaffold
- Prof Jos van den berg, Switzerland
- 1346 - 1352
- Abstract 2 (4+2) Temporal Validation of a Machine Learning-Powered Triage Algorithm for 30-Day Major Adverse Cardiovascular and Limb Events Following Endovascular Revascularisation
- Mr Bharadhwaj Ravindhran, Hull
- 1352 - 1405
- PANEL DISCUSSION
Acute Limb Ischaemia
Chairs: Mr Mark Portou & Prof Rob Morgan
- 1405 - 1415
- ALI at a Crossroads: What Will ESTABLISH and NCEPOD Teach Us?
- Mr Sandip Nandhra, Newcastle
- 1415 - 1425
- From Femoral to Pedal: Computer-Assisted Vacuum Thrombectomy Outcomes and Lessons from STRIDE II & the THRIVE Study
- Dr Andy Wigham, Oxford
- 1425 - 1435
- The ALI Case That Changed My Practice
- Mr Badri Vijaynagar, Leicester
- 1435 - 1450
- PANEL DISCUSSION
- 1450 - 1510
COFFEE BREAK
Evidence Session (III)
Chairs: Prof Athanasios Saratzis & Dr Stavros Spiliopoulos
- 1510 - 1520
- Do Claudicants Really Benefit from Intervention?
- Prof Athanasios Diamantopoulos, London
- 1520 - 1530
- Mechanical Angiogenesis: Can TTT Transform Outcomes in No-Option CLTI?
- Prof Anand Pillai, Manchester
- 1530 - 1540
- Pedal Acceleration Time: Hype or the New Gold Standard?
- Mr Mark Portou, London
- 1540 - 1550
- Shockwave IVL Below the Knee: Lessons from DISRUPT BTK II
- Prof Raghu Lakshminarayan, Hull
- 1550 - 1605
- PANEL DISCUSSION
BTK Disease
Chairs: Dr Shemin Mehta & Dr Ulrich Beschorner
- 1605 - 1615
- Angiosome vs Woundosome Revascularisation- Anecdote, Evidence or Simply Common sense
- Prof Jos van den berg, Switzerland
- 1615 - 1625
- Resorbable scaffolds in CLTI: Does the LIFE-BTK trial change practice? Who Benefits Most?
- Dr Stavros Spiliopoulos, Greece
- 1625 - 1635
- BTK Revascularisation: Which Technique for Which Patient?
- Dr Daniel Van Den Heuvel, Germany
- 1635 - 1645
- Long-term outcomes in patients undergoing percutaneous deep foot vein arterialization
- Dr Narayanan Thulasidasan, London
- 1645 - 1700
- PANEL DISCUSSION
- 1700 - 1705
- Close of Meeting